• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    101.38 Down 1.96(1.90%) Apr 17, 4:00PM EDT
    |After Hours : 101.40 Up 0.02 (0.02%) Apr 17, 7:59PM EDT
    Add to Portfolio
    Prev Close:103.34
    Open:102.30
    Bid:101.20 x 300
    Ask:101.44 x 100
    1y Target Est:119.08
    Beta:0.9
    Next Earnings Date:30-Apr-15GILD Earnings announcement
    Day's Range:100.61 - 102.81
    52wk Range:69.40 - 116.83
    Volume:9,896,452
    Avg Vol (3m):11,904,200
    Market Cap:151.00B
    P/E (ttm):13.79
    EPS (ttm):7.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 1.90%151.00B
    GSKDown 0.61%113.76B
    PFEDown 0.43%214.76B
    RHHBYDown 1.53%N/A

    Key Statistics

    Forward P/E (1 yr):9.75
    P/S (ttm):6.18
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :9.60
    Quarterly EPS Est (Mar-15) :2.28
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.81

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback